Therefore, to determine whether aberrant cytoplasmic localization of p16 also occurs in hepatocellular carcinoma, we stained a tissue microarray (TMA) containing human liver tumor samples. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.